Dai Ichi Life Insurance Company, LTD Regeneron Pharmaceuticals, Inc. Transaction History
Dai Ichi Life Insurance Company, LTD
- $3.54 Billion
- Q4 2024
A detailed history of Dai Ichi Life Insurance Company, LTD transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Dai Ichi Life Insurance Company, LTD holds 9,922 shares of REGN stock, worth $7.18 Million. This represents 0.2% of its overall portfolio holdings.
Number of Shares
9,922
Previous 12,392
19.93%
Holding current value
$7.18 Million
Previous $13 Million
45.75%
% of portfolio
0.2%
Previous 0.33%
Shares
24 transactions
Others Institutions Holding REGN
# of Institutions
1,488Shares Held
85.7MCall Options Held
1.53MPut Options Held
1.44M-
Vanguard Group Inc Valley Forge, PA9.29MShares$6.72 Billion0.12% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$6.11 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY7.06MShares$5.11 Billion0.41% of portfolio
-
State Street Corp Boston, MA4.83MShares$3.5 Billion0.14% of portfolio
-
Capital International Investors Los Angeles, CA4.74MShares$3.43 Billion0.66% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $77.5B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...